PELLIX Trademark

Trademark Overview

On Friday, October 30, 2020, a trademark application was filed for PELLIX with the United States Patent and Trademark Office. The USPTO has given the PELLIX trademark a serial number of 90290726. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 12, 2024. This trademark is owned by Medimetriks Pharmaceuticals, Inc.. The PELLIX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparation for dermatologic use in treating skin disorders
pellix

General Information

Serial Number90290726
Word MarkPELLIX
Filing DateFriday, October 30, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 12, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 11, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparation for dermatologic use in treating skin disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, December 27, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMedimetriks Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWest Fairfield, NJ 07004
Party NameMedimetriks Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWest Fairfield, NJ 07004

Trademark Events

Event DateEvent Description
Sunday, December 27, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 3, 2020NEW APPLICATION ENTERED
Wednesday, March 31, 2021ASSIGNED TO EXAMINER
Monday, April 5, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 21, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 11, 2021PUBLISHED FOR OPPOSITION
Tuesday, May 11, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 6, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sunday, October 24, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, December 10, 2021SOU TEAS EXTENSION RECEIVED
Sunday, October 24, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sunday, October 24, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Sunday, October 24, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 10, 2021SOU EXTENSION 1 FILED
Friday, December 10, 2021SOU EXTENSION 1 GRANTED
Tuesday, December 14, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 23, 2022SOU TEAS EXTENSION RECEIVED
Thursday, June 23, 2022SOU EXTENSION 2 FILED
Thursday, June 23, 2022SOU EXTENSION 2 GRANTED
Saturday, June 25, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 6, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, December 6, 2022SOU EXTENSION 3 FILED
Tuesday, December 6, 2022SOU EXTENSION 3 GRANTED
Thursday, December 8, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 13, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, June 13, 2023SOU EXTENSION 4 FILED
Tuesday, June 13, 2023SOU EXTENSION 4 GRANTED
Thursday, June 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 6, 2023SOU TEAS EXTENSION RECEIVED
Monday, November 6, 2023SOU EXTENSION 5 FILED
Wednesday, November 15, 2023SOU EXTENSION 5 GRANTED
Monday, November 13, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 12, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, August 12, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Thursday, November 16, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

pellix skin disorders treating dermatologic preparation pharmaceutical